Navigation Links
Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results
Date:2/13/2009

$7,377,921 $7,669,728 Accounts payable - related parties 1,104,312 714,776 Notes payable - banks 10,767,780 10,942,500 Short term loans 23,266,620 22,658,270 Accrued liabilities 257,281 261,187 Other payable 2,474,936 2,146,108 Employee loans 1,080,531 1,382,287 Employee loan - officer 53,871 53,605 Third party loan 242,783 640,228 Customer deposit 1,203,835 804,323 Taxes payable 2,863,436 4,631,252 Current portion of capital lease obligations 58,445 -- Total current liabilities 50,751,751 51,904,264 LONG TERM LIABILITIES: Capital lease obligation, net of current portion 5,076,055 -- Other payable - noncurrent 1,859,323 2,653,995 Total long term liabilities 6,935,378 2,653,995 Total liabilities 57,687,129 54,558,259 COMMITMENTS AND CONTINGENCIES -- -- SHAREHOLDERS' EQUITY: Preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued and outstanding -- -- Common stock, $0.001 par value, 100,000,000 shares authorized, 19,169,805 and 19,094,805 shares issued and outstanding as of December 31, 2008 and June 30, 2008, respectively 19,170 19,095 Paid-in capital 20,306,019 19,
'/>"/>
SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
2. Shengtai Pharmaceutical, Inc. Appoints New CFO
3. Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel
4. Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
5. Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call
6. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
7. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
9. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
10. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
11. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Diego, CA (PRWEB) December 23, 2014 ... where their Twitter followers can submit their #HolidayInTheLab ... themselves and their lab mates. , For those struggling ... lab mates, the Pipette.com Holiday in the Lab Contest ... Pipette.com Twitter followers to send pictures of ...
(Date:12/24/2014)... 23, 2014 Sigma-Aldrich Corporation (NASDAQ: ... period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR ... December 22, 2014, thereby completing the U.S. HSR ... acquisition of the Company by Merck KGaA, Darmstadt, ... another condition to closing the transaction, which remains ...
(Date:12/22/2014)... ROCKVILLE, Md. , Dec. 22, 2014 ... MKT: SYN), a developer of pathogen-specific therapies ... focus on protecting the microbiome, today announced ... a Phase 1a clinical trial of SYN-004, ... the prevention of Clostridium difficile (C. ...
(Date:12/22/2014)... 22, 2014  ( www.competitivehealth.com ) — Competitive Health ... bill review and advocacy service, has signed an agreement ... Savings discount health services marketplace. 63% of ... than they expected to pay. As part of an ... WellCard Savings is pleased to offer medical bill review ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2
... Graphene, a one-atom thick sheet of carbon ... "wonder material" that has taken scientific communities and ... material properties, such as high current-carrying capacity and ... components for semiconductor circuits and computers. Moreover, it ...
... improve photoelectrochemical cells. In the same way that plants ... use sunlight to drive chemical reactions that ultimately produce ... semi-conducting material such as cuprous oxide to provide the ... not expensive, the oxide is unstable if exposed to ...
... BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a biopharmaceutical ... financial results for the first quarter ended March 31, 2011 ... reported a net income of $3.7 million or $0.59 per ... diluted basis. The Company anticipates that it will be profitable ...
Cached Biology Technology:Why graphene holds the key to the future 2Harnessing the energy of the Sun: New technique improves artificial photosynthesis 2BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial Results 2BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial Results 3BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial Results 4BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial Results 5BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial Results 6BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial Results 7BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial Results 8
(Date:12/10/2014)... 8, 2014 You,ve been here before: you desperately ... remember your password, site key or the answer to your ... grade teacher? Today, Hoyos Labs , ... that will finally put an end to the frustration that ... . 1U leverages a user,s smartphone to acquire his ...
(Date:12/10/2014)... Dec. 08, 2014 Research and Markets ... of the "Biometrics Market in Japan 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 The integration ... as rural banking and upgradation of the driver,s ... in the market. Besides the aforementioned projects, biometrics ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... U.S. is produced by coal. Yet this power leaves behind ... College of Engineering at the University of Tennessee, Knoxville, has ... change that. Peter Liaw, professor and Ivan ... colleagues have received a $300,000 Clean Coal Research Award for ...
... this year,s Gulf of Mexico hypoxic zone could range from ... as 6,213 square miles. The wide range is the result ... on Mississippi River nutrient inputs compiled annually by the U.S. ... covering an area slightly larger than the state of Rhode ...
... been announced as the overall winner in this year,s Wellcome Image ... during a surgical procedure to treat a patient with epilepsy, the ... Professor Alice Roberts, who was a member of the judging panel, ... makes it so different from most images of the surface of ...
Cached Biology News:University of Tennessee professor receives funding for clean coal research 2NOAA: Gulf of Mexico 'dead zone' predictions feature uncertainty 2NOAA: Gulf of Mexico 'dead zone' predictions feature uncertainty 3Photograph of a living human brain is the overall winner of Wellcome Image Awards 2012 2
Immunogen: Human Respiratory Syncytial Virus (RSV) and Bovine Respiratory Syncytial Virus (BRSV) Fusion protein Storage: -20 C, Avoid Freeze/Thaw Cycles...
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
Tris-Hepes kit of BG-163 & BG-165 (order number BG-166)...
... Synthetic peptide derived from the C-terminal ... Specificity: Reacts with the human ... Human Mouse (positive controls: WNT1-transfected HEK293 ... and mouse Mouse-1 cell lysates). ...
Biology Products: